Saleh, E.; Soliman, O.A.; Attia, N.; Rafaat, N.; Baecker, D.; Teleb, M.; Ghazal, A.; Amer, A.N.
From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive Bacteria. Molecules 2025, 30, 2925.
https://doi.org/10.3390/molecules30142925
AMA Style
Saleh E, Soliman OA, Attia N, Rafaat N, Baecker D, Teleb M, Ghazal A, Amer AN.
From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive Bacteria. Molecules. 2025; 30(14):2925.
https://doi.org/10.3390/molecules30142925
Chicago/Turabian Style
Saleh, Ezzeldin, Omar A. Soliman, Nancy Attia, Nouran Rafaat, Daniel Baecker, Mohamed Teleb, Abeer Ghazal, and Ahmed Noby Amer.
2025. "From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive Bacteria" Molecules 30, no. 14: 2925.
https://doi.org/10.3390/molecules30142925
APA Style
Saleh, E., Soliman, O. A., Attia, N., Rafaat, N., Baecker, D., Teleb, M., Ghazal, A., & Amer, A. N.
(2025). From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive Bacteria. Molecules, 30(14), 2925.
https://doi.org/10.3390/molecules30142925
